These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4865079)

  • 1. [Prolonged anticoagulant therapy of patients after myocardial infarct].
    Szabolcs P
    Orv Hetil; 1967 Jun; 108(25):1172-4. PubMed ID: 4865079
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recurrence of myocardial infarct after discontinued administration of oral anticoagulants: fatal rebound for certain risk groups?].
    Beer J; Schlup P
    Schweiz Med Wochenschr; 1986 Apr; 116(14):429-31. PubMed ID: 3961458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with prolonged anticoagulant therapy at our outpatient clinic].
    Adler M; Gortvai G; Adamovits Z
    Orv Hetil; 1969 Sep; 110(39):2287-9. PubMed ID: 5350579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Thrombin and antithrombin activity" in patients with acute myocardial infarct and in subjects treated by anticoagulant therapy].
    Jean G; Praga C; Lambertenghi G; Cortellaro M
    Folia Cardiol; 1965; 24(5):282-90. PubMed ID: 5898888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Administration of long-term anticoagulant therapy in myocardial infarct].
    Alvarez JG
    Verh Dtsch Ges Kreislaufforsch; 1965; 31():325-7. PubMed ID: 5871274
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
    Michot F; Holt NF; Fontanilles F
    Schweiz Med Wochenschr; 1981 Feb; 111(8):255-60. PubMed ID: 7015495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
    Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of syncoumar on the status of the coagulating and anticoagulating systems of the blood in patients with myocardial infarct and chronic coronary insufficiency].
    Orlova NP
    Ter Arkh; 1966 Apr; 38(4):43-7. PubMed ID: 5984661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of metoprolol on infarct size after acute myocardial infarction (a double-blind study) (author's transl)].
    von Essen R; Merx W; Neis W; Ritz R
    Dtsch Med Wochenschr; 1982 Aug; 107(34):1267-73. PubMed ID: 7049656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hospital course of acute myocardial infarction treated with or without anticoagulants].
    Hurtado L; Adabache M; López Escárcega F; Cárdenas M
    Arch Inst Cardiol Mex; 1984; 54(5):463-70. PubMed ID: 6517643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction.
    Azar AJ; Koudstaal PJ; Wintzen AR; van Bergen PF; Jonker JJ; Deckers JW
    Ann Neurol; 1996 Mar; 39(3):301-7. PubMed ID: 8602748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant therapy of acute myocardial infarct and its sequelae].
    Sorensen OH; Friis T; Wjorgensen AW; Jorgensen MB; Bnissen NI
    Ugeskr Laeger; 1968 Feb; 130(8):318-27. PubMed ID: 5676619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
    Sámóczi M; Farkas A; Sipos E; Tarján J
    Orv Hetil; 1995 Jan; 136(4):177-9. PubMed ID: 7870411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Syncumar or low doses of heparin in the prevention of thromboembolism in acute myocardial infarct?].
    Rák K; Misz M; Boda Z; Udvardy M; Pfiegler G
    Orv Hetil; 1981 Nov; 122(46):2871-2. PubMed ID: 7322586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of sequelae after myocardial infarct. Results, methods and problems of a prospective multi-center study of the effect of acetylsalicylic acid, phenprocoumon and placebo].
    Breddin HK; Uberla KK
    Verh Dtsch Ges Inn Med; 1980; 86():1338-48. PubMed ID: 7013326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tolbutamide treatment after myocardial infarct].
    Paasikivi J
    Nord Med; 1970 Sep; 84(38):1210. PubMed ID: 4918867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of sudden death after myocardial infarct with chronic alprenolol treatment].
    Tibblin G; Vedin A; Wilhelmsen L; Werkö L; Wilhelmsson C
    Lakartidningen; 1975 Jun; 72(25):2683-6. PubMed ID: 1095869
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.
    Paasikivi J
    Acta Med Scand Suppl; 1970; 507():1-82. PubMed ID: 4948308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of streptodecase in treating myocardial infarct patients].
    Gvatua NA; Shumakov VA; Lenchevskaia IF; Malinovskaia IE; Shkliar LV
    Vrach Delo; 1984 Oct; (10):48-51. PubMed ID: 6393581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.